Reproductive Health 2010 – 2010 Oral and Poster Abstracts

 

Accreditation | Awards and Lectureships | How will I receive my continuing education (CE) credits? | Faculty and Moderators | Final Agenda | Final Program | Oral and Poster Abstracts | Other Information | Presentations | Virtual Take-One Table

Oral Abstracts

O01 THE UTILITY OF SONOGRAPHIC ASSESSMENT OF INTRAUTERINE DEVICE PLACEMENT FOLLOWING IMMEDIATE VERSUS DELAYED INSERTION FOLLOWING UTERINE ASPIRATION
O02 TXT NOW 2 DECREASE PREGNANCIES L8R: A RANDOMIZED CONTROL TRIAL TO EVALUATE THE EFFECT OF DAILY EDUCATIONAL TEXT MESSAGES ON ORAL CONTRACEPTIVE CONTINUATION IN YOUNG URBAN WOMEN
O03 THE SAFETY OF DIGOXIN AS A FETICIDAL AGENT
O04 MUSIC AS AN AUXILIARY ANALGESIC DURING FIRST TRIMESTER SURGICAL ABORTION: A RANDOMIZED CONTROL TRIAL
O05 INTRODUCING MEDICAL ABORTION IN NEPAL WITH MINIMAL TECHNOLOGY
O06 A DOUBLE-BLINDED RANDOMIZED TRIAL OF SAME-DAY DILAPAN-S VERSUS OVERNIGHT LAMINARIA FOR CERVICAL PREPARATION BEFORE SURGICAL ABORTION BETWEEN FOURTEEN AND EIGHTEEN WEEKS’ GESTATION
O07 EARLY WEIGHT GAIN AND ITS RELATIONSHIP TO LATER WEIGHT GAIN IN ADOLESCENTS ON DMPA
O08 THE IMPACT OF PACK SUPPLY ON ORAL CONTRACEPTIVE CONTINUATION: A RANDOMIZED CONTROLLED TRIAL
O09 DO DEPRESSED MOOD, PSYCHOLOGICAL STRESS AND EATING DISORDERED SYMPTOMS INCREASE THE RISK FOR ORAL CONTRACEPTIVE DISCONTINUATION IN YOUNG MINORITY WOMEN?
O10 DOES CONVENIENCE MATTER? ORAL CONTRACEPTIVE CONTINUATION ALONG THE US-MEXICO BORDER
O11 COMPARISON OF THE INCIDENCE OF PELVIC INFLAMMATORY DISEASE IN INTRAUTERINE DEVICES USERS BY GONORRHEA AND CHLAMYDIA SCREENING STRATEGIES
O12 RATES OF CONTINUATION AND EXPULSION OF INTRAUTERINE CONTRACEPTION AT 12 MONTHS IN NULLIPAROUS AND ADOLESCENT WOMEN
O13 STRUCTURED CONTRACEPTIVE COUNSELING: A RANDOMIZED CONTROLLED TRIAL
O14 CAN PARENTS TEACH THEIR TEENS TO HAVE SAFE SEX? RESULTS OF AN EDUCATIONAL INTERVENTION FOR PARENTS IN MEXICO
O15 RANDOMIZED TRIAL OF HOME VERSUS CLINIC-BASED SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS IN LONG-ACTING REVERSIBLE CONTRACEPTIVE USERS
O16 REVITALIZING LONG ACTING REVERSIBLE CONTRACEPTIVES IN SETTINGS WITH HIGH UNMET NEED:  A MULTI-COUNTRY EXPERIENCE MATCHING DEMAND CREATION AND SERVICE DELIVERY
O17 PROPHYLACTIC MISOPROSTOL PRIOR TO IUD INSERTION IN NULLIPAROUS WOMEN
O18 RESUMPTION OF SEXUAL ACTIVITY AFTER FIRST TRIMESTER SUCTION ASPIRATION
O19 PREGNANCY INTENTIONS AND FAMILY PLANNING PREFERENCES AMONG HIV-INFECTED WOMEN IN NYANZA PROVINCE, KENYA
020 CONTRACEPTIVE AND PREGNANCY OUTCOMES: A RANDOMIZED CONTROLLED TRIAL OF IMMEDIATE VERSUS DELAYED POST-ABORTAL COPPER T 380A IUD INSERTION AFTER SECOND TRIMESTER ABORTIONS
021 STI/PREGNANCY PREVENTION USING TECHNOLOGY-BASED EDUCATION

Poster Abstracts

P01 A RANDOMIZED TRIAL OF IMMEDIATE VERSUS DELAYED INSERTION OF THE COPPER T 380Q FOLLOWING MEDICATION ABORTION
P02 PAIN FOLLOWING POST-ASPIRATION IUD INSERTION
P03 USING QUALITATIVE METHODS TO EXPLORE EC USERS WILLINGNESS TO ACCEPT THE COPPER IUD
P04 TRANSCESAREAN IUD INSERTION: A PROSPECTIVE COHORT STUDY
P05 RATES OF EXPULSION AT 6 MONTHS IN WOMEN UNDERGOING IMMEDIATE POSTABORTION INTRAUTERINE CONTRACEPTION INSERTION
P06 ESTIMATED COST SAVINGS WITH PROVIDING UNIVERSAL CONTRACEPTION IN THE STATE OF OREGON
P07 PREDICTORS OF PATIENT USE OF HIGHLY EFFECTIVE POST-PARTUM CONTRACEPTION
P08 EFFECTS OF ST. JOHN’S WORT ON THE PHARMACOKINETICS OF LEVONORGESTREL IN EMERGENCY CONTRACEPTIVE (EC) DOSING
P09 EVALUATION OF ORAL CONTRACEPTIVE EFFECTIVENESS IN A LARGE COHORT STUDY – IS ELEVATED BMI ASSOCIATED WITH REDUCED ORAL CONTRACEPTIVE EFFECTIVENESS?
P10 COMPARING THE CONTRACEPTIVE DECISION-MAKING OF WOMEN WHO CHOOSE AN INTRAUTERINE DEVICE VERSUS A LESS EFFECTIVE METHOD: A QUALITATIVE ANALYSIS
P11 COMPARING OUTCOMES FOLLOWING IMMEDIATE OR DELAYED LEVONORGESTREL-IUD INSERTION AFTER DILATION AND CURETTAGE, DILATION AND EVACUATION AND VAGINAL DELIVERY
P12 CONTRACEPTIVE USE AMONG WOMEN OBTAINING ABORTIONS IN 2008
P13 COUPLES-BASED FAMILY PLANNING SERVICES: IS THERE A NEED?
P14 LEVONORGESTREL RELEASE RATES WITH LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA
P15 KNOWLEDGE OF CONTRACEPTIVE EFFECTIVENESS AMONG A COHORT OF ST. LOUIS WOMEN CHOOSING REVERSIBLE CONTRACEPTION
P16 PLASMA LEVONORGESTREL LEVELS IN WOMEN USING LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA
P17 CONTINUATION AND SATISFACTION OF REVERSIBLE CONTRACEPTION: A PRELIMINARY ANALYSIS FROM THE CONTRACEPTIVE CHOICE PROJECT
P18 UNDERSTANDING THE ATTITUDES OF BLACK, LATINO, AND WHITE COUPLES TOWARDS STERILIZATION
P19 CARBAMAZEPINE COADMINISTRATION WITH AN ORAL CONTRACEPTIVE: EFFECTS ON STEROID PHARMACOKINETICS, OVULATION AND BLEEDING
P20 WHAT DO WOMEN WANT? WOMEN’S EXPERIENCES AND PREFERENCES ABOUT CONTRACEPTIVE COUNSELING: A QUALITATIVE STUDY
P21 PAIN WITH IUD INSERTION FOLLOWING PROPHYLACTIC IBUPROFEN: A RANDOMIZED TRIAL
P22 US ADOLESCENT EXPERIENCE WITH INTRAUTERINE DEVICE INSERTION AND USE: A RETROSPECTIVE STUDY
P23 EMERGENCY CONTRACEPTION KNOWLEDGE AND LIKELIHOOD OF USE BY WOMEN WITH RECENT POOR PERINATAL OUTCOMES
P24 CONTRACEPTIVE CHOICES IN PATIENTS WITH LOW LITERACY SKILLS
P25 WHAT FACTORS INFLUENCE WOMEN’S CONTRACEPTIVE DECISIONS?
P26 FAMILY PLANNING PROVIDER ATTITUDES AND PRACTICES RELATED TO PROVISION OF CONTRACEPTIVE METHODS AMONG WOMEN WITH VARIOUS CHARACTERISTICS AND MEDICAL CONDITIONS
P27 MEDICAL STUDENT INTRAUTERINE CONTRACEPTION KNOWLEDGE AND ATTITUDES: EVALUATION OF OBSTETRIC AND GYNECOLOGY CLERKSHIP TRAINING
P28 ASSOCIATION OF AGE AND LARC METHOD CHOICE IN THE CONTRACEPTIVE CHOICE PROJECT
P29 UNMET NEED FOR PUBLICLY FUNDED FAMILY PLANNING IN REGION IV
P30 PREVALENCE OF CHLAMYDIA TRICHOMATIS AND NEISSERIA GONORRHOEA IN PATIENTS REQUESTING IUD AS POST ABORTION CONTRACEPTION IN A PUBLICLY FUNDED PREGNANCY TERMINATION CLINIC
P31 GIVING YOUNG WOMEN IN KENYA AN OPPORTUNITY TO USE IMPLANTS INSTEAD OF SHORT-ACTING METHODS: PROSPECTIVE STUDY TO MEASURE ACCEPTABILITY AND BENEFITS
P32 FACTORS ASSOCIATED WITH CHOOSING A LONG ACTING REVERSIBLE CONTRACEPTIVE METHOD AMONGST POSTPARTUM WOMEN IN AN URBAN TEACHING HOSPITAL
P33 EFFECT OF SUBCUTANEOUS DEPO-MEDROXYPROGESTERONE ACETATE SUBCUTANEOUS (DEPOT-MEDROXYPROGESTERONE ACETATE) ON SERUM ANDROGENIC MARKERS IN NORMAL WEIGHT, OBESE AND EXTREMELY OBESE WOMEN
P34 BARRIERS TO CONTRACEPTIVE USE IN TASBA-PRI, NICARAGUA
P35 COMMUNITY-BASED PROVISION OF DMPA IN TIGRAY, ETHIOPIA: TASK SHIFTING TO REACH WOMEN
P36 IUD REMOVALS IN THE EMERGENCY DEPARTMENT SETTING
P37 RATES OF INTRAUTERINE DEVICE DISCONTINUATION AFTER ABORTION VS. INTERVAL PLACEMENT
P38 METHOD SATISFACTION AMONG USERS OF POST PARTUM IUD IN EL SALVADOR
P39 OVARIAN SUPPRESSION IN NORMAL-WEIGHT AND OBESE WOMEN USING A CONTRACEPTIVE VAGINAL RING
P40 OVARIAN FOLLICULAR DEVELOPMENT DURING SIX WEEK EXTENDED USE OF A SINGLE CONTRACEPTIVE VAGINAL RING
P41 CONTINUATION AND ACCEPTABILITY OF THE LEVONORGESTREL INTRAUTERINE SYSTEM AND DEPO-MEDROXYPROGESTERONE ACETATE AMONG ADOLESCENTS AND YOUNG WOMEN
P42 THE EFFECT OF PARITY ON REASONS FOR REMOVAL OF A LEVONORGESTREL IUS
P43 SELF-ADMINISTRATION OF SUBCUTANEOUS DEPOT MEDROXYPROGESTERONE ACETATE BY ADOLESCENT WOMEN
P44 PROVISION OF POSTPARTUM CONTRACEPTION IN WOMEN WITH CHRONIC MEDICAL CONDITIONS
P45 USE OF A SELF-ADMINISTERED COMPUTER MODULE PROVIDING PERSONALIZED CONTRACEPTIVE RECOMMENDATIONS IN A CLINICAL SETTING
P46 COST ANALYSIS OF HYSTEROSCOPIC STERILIZATION VERSUS THE INTRAUTERINE DEVICE AS LONG-TERM CONTRACEPTION
P47 IBUPROFEN PROPHYLAXIS FOR LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM INSERTION: A RANDOMIZED CONTROLLED TRIAL
P48 PROVIDER OPINIONS ABOUT EXPANDING ACCESS TO HORMONAL CONTRACEPTION
P49 NUMBER OF ORAL CONTRACEPTIVE PILL PACKAGES DISPENSED AND SUBSEQUENT UNINTENDED PREGNANCIES
P50 LENGTH OF TIME AFTER INSERTION FOR THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM FOR IT TO SIGNIFICANTLY ALTER CERVICAL MUCUS QUALITY AND SPERM PENETRABILITY
P51 CONTRACEPTIVE CHOICES OF ADOLESCENTS IN A LARC-ORIENTED ADOLESCENT TITLE X CLINIC
P52 BARRIERS TO POST-PARTUM IUC USE: IMPLICATIONS FOR PATIENT CONTRACEPTIVE PREFERENCES AND SATISFACTION WITH HEALTH SERVICES
P53 THE IMPACT OF INSURANCE COVERAGE ON IUD UTILIZATION
P54 CHARACTERISTICS OF WOMEN WHO FAIL TO RETURN FOR DELAYED IUD INSERTION FOR POST-ABORTION CONTRACEPTION
P55 USE OF EFFECTIVE CONTRACEPTIVE METHODS AMONG WOMEN TAKING TERATOGENIC MEDICATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
P56 ARE THERE DIFFERENCES? SHBG LEVELS, FREE TESTOSTERONE AND SEXUAL PAIN IN WOMEN USING COMBINED HORMONAL CONTRACEPTION: A RETROSPECTIVE STUDY IN VULVODYNIA PATIENTS
P57 PARTNERSHIP CHARACTERISTICS AS PREDICTORS FOR CHOOSING A VERY EFFECTIVE CONTRACEPTIVE METHOD
P58 UNMET DEMAND FOR STERILIZATION AMONG LATINAS
P59 EXAMINING THE INFLUENCE OF MATERNAL CHARACTERISTICS ON THE USE OF CONTRACEPTION AFTER ABORTION IN THE UNITED STATES USING THE 2002 NATIONAL SURVEY OF FAMILY GROWTH
P60 MEDICAL VERSUS SURGICAL ABORTION: THE IMPORTANCE OF WOMEN’S CHOICE
P61 WOMEN’S ATTITUDES AND BEHAVIORS TOWARD UNPLANNED PREGNANCY: A PROSPECTIVE STUDY
P62 CHANGES IN SERVICE DELIVERY PATTERNS AFTER LAUNCHING TELEMEDICINE PROVISION OF MEDICATION ABORTION IN IOWA
P63 HAS MIFEPRISTONE MEDICAL ABORTION EXPANDED ABORTION ACCESS IN NEW MEXICO? A SURVEY OF OB/GYN AND FAMILY MEDICINE PHYSICIANS
P64 REPRODUCTIVE HEALTH PROGRAM: OUTCOMES OF A UNIQUE ABORTION TRAINING PROGRAM
P65 “ARE WE EVEN SPEAKING THE SAME LANGUAGE?”: CONTESTED DEFINITIONS OF RAPE, INCEST, AND LIFE ENDANGERMENT UNDER THE HYDE AMENDMENT
P66 STANDARDIZING EARLY ABORTION COMPLICATION DEFINITIONS AND TRACKING: TESTING AN EVIDENCE-BASED FRAMEWORK
P67 OVULATION RESUMPTION AFTER MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL
P68 PRELIMINARY RESULTS OF THE ROLE OF SEMIQUANTITATIVE PREGNANCY TESTS IN MEDICAL ABORTION PROVISION
P69 PREVENTING REPEAT ABORTION: IS THE IMMEDIATE INSERTION OF INTRAUTERINE DEVICES POST-ABORTION ASSOCIATED WITH FEWER REPEAT ABORTIONS IN A CANADIAN POPULATION?
P70 DILATION AND EVACUATION VS. LABOR INDUCTION FOR FETAL INDICATIONS: A RETROSPECTIVE COHORT STUDY
P71 ABORTION PRACTICE AND NEED FOR TRAINING IN MEXICO: RESULTS FROM A SURVEY OF MEXICAN PROVIDERS AT THE 2009 ANNUAL OBSTETRICS AND GYNECOLOGY SPECIALTY CONFERENCE
P72 CONTRACEPTIVE CHOICES OF OVERWEIGHT AND OBESE WOMEN IN A PUBLICALLY FUNDED HOSPITAL: CLINICAL IMPLICATIONS
P73 IMPACT OF GESTATIONAL AGE ON PAIN PERCEPTION DURING FIRST TRIMESTER SURGICAL ABORTION
P74 IMPACT OF A SPECIALTY ROTATION IN FAMILY PLANNING ON OBSETRICS AND GYNEOCLOGY RESIDENTS’ SELF-ASSESSMENT OF COMPETENCY AND INTENTIONS TO PROVIDE ABORTION SERVICES AFTER GRADUATION
P75 THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL AT 57-63 DAYS VERSUS 64-70 DAYS GESTATION
P76 MUSIC IN SURGICAL ABORTION CARE: A RANDOMIZED CONTROLLED PILOT STUDY
P77 CAN THE PROSPECT OF INFERTILITY MOTIVATE YOUNG WOMEN’S INTENTIONS TO SEEK PREVENTIVE HEALTHCARE? FINDINGS FROM CDC CONCEPT TESTING FOCUS GROUPS
P78 HIGH-RISK SEXUAL BEHAVIOUR IN A RANDOM SAMPLE OF >22,000 MEN FROM THE GENERAL POPULATION IN DENMARK
P79 EXPERIENCES OF DISCRIMINATION AND STI TESTING IN WHITE AND BLACK WOMEN
P80 MISSED OPPORTUNITIES FOR CHLAMYDIA RETESTING AT LIMITED SERVICE VISITS IN CALIFORNIA FAMILY PLANNING CLINICS
P81 THE BABOON (PAPIO ANUBIS) AS A NOVEL MODEL OF CHLAMYDIA TRACHOMATIS PELVIC INFLAMMATORY DISEASE FOR TESTING INTRAUTERINE CONTRACEPTION
P82 IMIQUIMOD 2.5% AND 3.75% APPLIED DAILY FOR UP TO 8 WEEKS TO TREAT EXTERNAL GENITAL WARTS
P83 ELDERLY PERSON’S REPRODUCTIVE HEALTH CHALLENGES AND INVOLVEMENT IN RISKY SEXUAL ACTIVITIES IN IKORODU, NIGERIA
P84 PREDICTORS OF SEXUAL SATISFACTION AMONG YOUNG ADULTS IN THE UNITED STATES
P85 REPRODUCTIVE AND SEXUAL HEALTH IN MENTALLY ILL
P86 SEXUAL INTIMATE PARTNER VIOLENCE, SEXUAL RISK BEHAVIORS, AND CONTRACEPTIVE PRACTICES AMONG WOMEN OF AFRICAN DESCENT
P87 REPRODUCTIVE HEALTHCARE NEEDS OF HIV-POSITIVE WOMEN
P88 CONTRACEPTIVE KNOWLEDGE, ATTITUDES, AND PRACTICES AMONG HIV-INFECTED WOMEN AND MEN RECEIVING HIV CARE AND TREATMENT IN NYANZA PROVINCE, KENYA
P89 HIGH CONTRACEPTION USE AND LOW PREGNANCY RATE AMONG HIV POSITIVE WOMEN ATTENDING A POSTNATAL PROGRAM IN LILONGWE, MALAWI
P90 INTRAUTERINE LIDOCAINE INFUSION FOR PAIN MANAGEMENT DURING OUTPATIENT TRANSCERVICAL TUBAL STERILIZATION
P91 RISK FACTORS FOR AND CONSEQUENCES OF UNINTENDED PREGNANCY AMONG LATINA AND WHITE POPULATIONS IN UTAH, 2004-2007
P92 COMPARISON OF LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA FOR TREATMENT FOR MENORRHAGIA
P93 PRESUMPTIVE TREATMENT OF ABNORMAL EARLY PREGNANCY OF UNKNOWN LOCATION
P94 VAGINAL AND RECTAL CLOSTRIDIAL COLONIZATION AMONG WOMEN OF REPRODUCTIVE AGE IN THE UNITED STATES
P95 TWO-STAGE CLUSTER SAMPLING WITH REFERRAL: IMPROVING THE EFFICIENCY OF ESTIMATING UNMET NEEDS AMONG PREGNANT AND POSTPARTUM WOMEN AFTER FLOODING IN NORTHWEST GEORGIA, SEPTEMBER 2009
P96 RURAL REPRODUCTIVE HEALTH: BARRIERS AND FACILITATORS EXPERIENCED BY LOW-INCOME RURAL WOMEN IN OBTAINING REPRODUCTIVE HEALTH CARE SERVICES
P97 EFFECT OF A “CONTRACEPTIVE VITAL SIGN” IN PRIMARY CARE: A RANDOMIZED CONTROLLED TRIAL
P98 ASSOCIATION BETWEEN ECONOMIC VULNERABILITY AND WOMEN’S PREGNANCY INTENTIONS
P99 IMPACT OF LENGTH OF FORMAL FAMILY PLANNING TRAINING ON SELF-ASSESSED COMPETENCE AND PROCEDURE VOLUME OF ABORTION PROCEDURES
P100 IMPACT OF FORMAL FAMILY PLANNING TRAINING ON OB-GYN RESIDENTS SKILLS AND EXPOSURE IN CONTRACEPTION PROVISION
P101 INNOVATION IN EMERGENCY OBSTETRIC TRAINING, PRONTO2: AN IN SITU MULTI-DISCIPLINARY, LOW-TECH, HIGH-FIDELITY SIMULATION-BASED CURRICULUM FOR MEXICO, RESULTS OF A PILOT IMPLEMENTATION STUDY
P102 CONTRACEPTION USE AFTER AN UNPLANNED PREGNANCY